CN105412390A - 一种调节气血保健软胶囊 - Google Patents
一种调节气血保健软胶囊 Download PDFInfo
- Publication number
- CN105412390A CN105412390A CN201510807176.2A CN201510807176A CN105412390A CN 105412390 A CN105412390 A CN 105412390A CN 201510807176 A CN201510807176 A CN 201510807176A CN 105412390 A CN105412390 A CN 105412390A
- Authority
- CN
- China
- Prior art keywords
- extract
- soft capsule
- blood
- health
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 36
- 210000004369 blood Anatomy 0.000 title claims abstract description 36
- 239000007901 soft capsule Substances 0.000 title claims abstract description 28
- 230000001105 regulatory effect Effects 0.000 title abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 63
- REFJWTPEDVJJIY-UHFFFAOYSA-N quercetin Natural products C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims abstract description 25
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 14
- 240000006053 Garcinia mangostana Species 0.000 claims abstract description 13
- 235000017048 Garcinia mangostana Nutrition 0.000 claims abstract description 13
- 229920001202 Inulin Polymers 0.000 claims abstract description 13
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims abstract description 13
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229920002770 condensed tannin Polymers 0.000 claims abstract description 13
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 13
- 229940029339 inulin Drugs 0.000 claims abstract description 13
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000018192 pine bark supplement Nutrition 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 229940106796 pycnogenol Drugs 0.000 claims abstract description 13
- 229960001285 quercetin Drugs 0.000 claims abstract description 13
- 235000005875 quercetin Nutrition 0.000 claims abstract description 13
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 13
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 12
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 12
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 12
- 235000012424 soybean oil Nutrition 0.000 claims abstract description 11
- 239000003549 soybean oil Substances 0.000 claims abstract description 11
- 230000036541 health Effects 0.000 claims description 29
- 210000000582 semen Anatomy 0.000 claims description 24
- 239000003292 glue Substances 0.000 claims description 21
- 235000003935 Hippophae Nutrition 0.000 claims description 13
- 241000229143 Hippophae Species 0.000 claims description 13
- 108010033040 Histones Proteins 0.000 claims description 12
- 235000009392 Vitis Nutrition 0.000 claims description 12
- 241000219095 Vitis Species 0.000 claims description 12
- 229960003495 thiamine Drugs 0.000 claims description 12
- 239000011721 thiamine Substances 0.000 claims description 12
- 239000007766 cera flava Substances 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 10
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 abstract 2
- 235000017060 Arachis glabrata Nutrition 0.000 abstract 1
- 244000105624 Arachis hypogaea Species 0.000 abstract 1
- 235000010777 Arachis hypogaea Nutrition 0.000 abstract 1
- 235000018262 Arachis monticola Nutrition 0.000 abstract 1
- 240000000950 Hippophae rhamnoides Species 0.000 abstract 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 abstract 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 abstract 1
- 241001138808 Lampranthus spectabilis Species 0.000 abstract 1
- 235000013871 bee wax Nutrition 0.000 abstract 1
- 229940087603 grape seed extract Drugs 0.000 abstract 1
- 235000002532 grape seed extract Nutrition 0.000 abstract 1
- 230000003394 haemopoietic effect Effects 0.000 abstract 1
- 235000020232 peanut Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- -1 quercetin phospholipid Chemical class 0.000 abstract 1
- 239000001717 vitis vinifera seed extract Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 5
- 208000007502 anemia Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000002607 hemopoietic effect Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004905 finger nail Anatomy 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010057315 Daydreaming Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- DAHIQPJTGIHDGO-IRXDYDNUSA-N Mesembrine Chemical compound C1=C(OC)C(OC)=CC=C1[C@@]1(CCC(=O)C2)[C@H]2N(C)CC1 DAHIQPJTGIHDGO-IRXDYDNUSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010048222 Xerosis Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000004855 vascular circulation Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- PQBHZMSTECYZLH-UHFFFAOYSA-N C1=C(OC)C(OC)=CC=C1C1(C=CC(O)C2)C2N(C)CC1 Chemical compound C1=C(OC)C(OC)=CC=C1C1(C=CC(O)C2)C2N(C)CC1 PQBHZMSTECYZLH-UHFFFAOYSA-N 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001093152 Mangifera Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 102000002151 Microfilament Proteins Human genes 0.000 description 1
- 108010040897 Microfilament Proteins Proteins 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241001591005 Siga Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000037328 acute stress Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- PQBHZMSTECYZLH-JQFCIGGWSA-N mesembrenol Natural products COc1ccc(cc1OC)[C@]23CCN(C)[C@H]2C[C@@H](O)C=C3 PQBHZMSTECYZLH-JQFCIGGWSA-N 0.000 description 1
- DAHIQPJTGIHDGO-UHFFFAOYSA-N mesembrine Natural products C1=C(OC)C(OC)=CC=C1C1(CCC(=O)C2)C2N(C)CC1 DAHIQPJTGIHDGO-UHFFFAOYSA-N 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000004793 poor memory Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种调节气血保健软胶囊。其是由软胶囊体和封装在软胶囊体内的内容物组成,特点是:其内容物是由下列重量百分比的组分组成:枸杞提取物3.5~7%、沙棘籽油2.5~4%、葡萄籽提取物1~3%、花生组织蛋白0.5~2.5%、槲皮素磷脂复合物1~3%、松叶菊提取物0.5~1.35%、L-茶氨酸0.5~2%、山竹提取物0.5~1.25%、碧萝芷提取物1~4%、菊粉2~7.5%、果味粉5~7%、大豆油55~65%、蜂蜡3~10%、磷脂2~7%,且各组分的重量百分比之和为100%。本发明的调节气血保健软胶囊组成科学、配比恰当、服用方便,具有补肝益肾、活血行气、增强血管循环、促进机体造血功能及改善皮肤的功效。
Description
技术领域
本发明涉及医用配制品,尤其是一种调节气血保健软胶囊。
背景技术
随着社会的进步,人们生活节奏的加快,人们的饮食结构及紧张的生活方式使人体长期疲劳得不到有效缓解,使身体处于一种亚健康状态。这种情况如果长期得不到改善,这种情况如果长期得不到改善,就会出现贫血、心悸、气短、头晕、神经衰弱、失眠、精神不振、腰酸背痛、记忆力差等症状,表现在容颜上的问题是:脸色暗黄、无光泽、黑色素沉着、皮肤松弛、黄褐斑等。
中医认为,“气为血之帅,血为气之母”。血液是人体生命活动的重要物质基础,它含有人体所需要的各种营养物质,在心肺之气共同作用之下,内至脏腑,外达筋骨,对全身各脏腑组织起着营养作用。但如果由于各种原因引起气血亏虚则可出现一系列的病证。
现有市场上出现的改善和治疗气血两虚的产品可以分为三部类:铁剂、中成药和保健品。其中,铁剂主要针对缺铁性贫血,而调节气血的铁剂多为葡萄糖酸亚铁、硫酸亚铁等成分的化学药物,但这类药物对人体会产生恶心、腹部疼痛、腹泻、便秘等不良反应。中成药又存在重金属超标的可能性,限制了其应用。那么既食用方便安全又能养生的保健品就成为调节气血的首选。而目前,市场上还未发现专门用于调节气血的保健品。因此,研制一种即能调节气血又食用方便、安全、大众化的保健品是一亟待解决的问题。
发明内容
本发明的目的是提供一种组成合理、配比恰当、具有增强血管循环、促进机体造血功能及改善皮肤等功效的调节气血保健软胶囊。
本发明解决其技术问题所采用的技术方案是:一种调节气血保健软胶囊,其特征在于:其是由软胶囊体和封装在软胶囊体内的内容物组成,软胶囊体由明胶、甘油、水按常规比例制成,其特征在于:所述的内容物是由下列重量百分比的组分组成:枸杞提取物3.5~7%、沙棘籽油2.5~4%、葡萄籽提取物1~3%、花生组织蛋白0.5~2.5%、槲皮素磷脂复合物1~3%、松叶菊提取物0.5~1.35%、L-茶氨酸0.5~2%、山竹提取物0.5~1.25%、碧萝芷提取物1~4%、菊粉2~7.5%、果味粉5~7%、大豆油55~65%、蜂蜡3~10%、磷脂2~7%,且各组分的重量百分比之和为100%。
本发明的优选技术方案是:所述内容物组分的重量百分比分别为:枸杞提取物5.2%、沙棘籽油3.8%、葡萄籽提取物1.2%、花生组织蛋白1.4%、槲皮素磷脂复合物1.6%、松叶菊提取物0.9%、L-茶氨酸0.8%、山竹提取物0.9%、碧萝芷提取物2.2%、菊粉6%、果味粉6%、大豆油60%、蜂蜡6%、磷脂4%。
本发明是依据我国的中医理论与食疗相结合,选取天然组分组合而成。本发明所选取的原料成分中,枸杞提取物、沙棘籽油、葡萄籽提取物、花生组织蛋白、槲皮素磷脂复合物、松叶菊提取物、L-茶氨酸、山竹提取物、碧萝芷提取物、菊粉、果味粉均为植物提取物,均是市购产品。其中,枸杞有明显促进正常小鼠造血功能的作用,枸杞多糖还可以增强骨髓造血功能,具有抗衰老作用;沙棘籽油中的沙棘黄酮及其它酚类化合物,β-谷固醇、甜菜碱等活性物质可以改善血液循环,清除血管壁的沉积物,恢复血管弹性,增加冠状动脉血流量,降低心肌耗氧量,增强心功能等;葡萄籽提取物含丰富生物类黄酮、是强力的精华分子,用于对抗自由基(游离基)与维护微丝血管的健康;花生组织蛋白的水解度对其抗氧化性和ACE抑制活性有显著影响;槲皮素磷脂复合物可提高皮肤的含水量且可促使受损皮肤快速修复,能有效的减轻皮肤不良反应,对各种皮肤刺激具有舒缓功效;松叶菊提取物中的生物碱,共有四种主要的活性成分,包括松叶菊酮碱、mesembrenol、松叶菊碱和番杏碱,具有消除压力改善情绪的作用;L-茶氨酸可以增加大脑中的多巴胺、血清素的含量,并可抑制甘氨酸的神经递质,可控制心率和唾液分泌SIgA,由此减弱急性应激,提高睡眠质量;山竹提取物中的氧杂蒽酮的一种α-倒捻子素有显著的抗氧化性,并具有抗发炎、抗菌的作用;碧萝芷提取物是一种天然的抗炎物质、强力抗氧剂、可以与胶原和弹力素进行选择性结合、可以帮助产生内皮的一氧化氮以帮助血管扩张;菊粉可减低血糖值、淡化血糖的浓度、改善血管障碍、快速增加肠道内双歧杆菌数量;各种口味的果味粉可满足不同人群的需要。本发明的原料组分相互佐助,协同作用,共奏补肝益肾、活血行气、增强血管循环、促进机体造血功能及改善皮肤的功效。本发明组成科学、组分天然、配比恰当、服用方便、口感好、功效显著,是一种理想、高端健康、无副作用的调节气血的保健食品。
具体实施方式
下面结合实施例对本发明做进一步说明。
实施例1
一种调节气血保健软胶囊,其是由软胶囊体和封装在软胶囊体内的内容物组成,其内容物是由下列重量百分比的组分组成:枸杞提取物5.2%、沙棘籽油3.8%、葡萄籽提取物1.2%、花生组织蛋白1.4%、槲皮素磷脂复合物1.6%、松叶菊提取物0.9%、L-茶氨酸0.8%、山竹提取物0.9%、碧萝芷提取物2.2%、菊粉6%、果味粉6%、大豆油60%、蜂蜡6%、磷脂4%。
实施例2
一种调节气血保健软胶囊,其是由软胶囊体和封装在软胶囊体内的内容物组成,其内容物是由下列重量百分比的组分组成:枸杞提取物7%、沙棘籽油2.5%、葡萄籽提取物2.2%、花生组织蛋白2.5%、槲皮素磷脂复合物2%、松叶菊提取物0.5%、L-茶氨酸0.5%、山竹提取物1.5%、碧萝芷提取物2.3%、菊粉2%、奶茶果味粉7%、大豆油55%、蜂蜡8%、磷脂7%。
实施例3
一种调节气血保健软胶囊,其是由软胶囊体和封装在软胶囊体内的内容物组成,其内容物是由下列重量百分比的组分组成:枸杞提取物5.4%、沙棘籽油3.1%、葡萄籽提取物3%、花生组织蛋白2.2%、槲皮素磷脂复合物1.6%、松叶菊提取物1.1%、L-茶氨酸0.5%、山竹提取物0.5%、碧萝芷提取物4%、菊粉2.8%、苹果果味粉5.8%、大豆油65%、蜂蜡3%、磷脂2%。
实施例4
一种调节气血保健软胶囊,其是由软胶囊体和封装在软胶囊体内的内容物组成,其内容物是由下列重量百分比的组分组成:枸杞提取物6.2%、沙棘籽油2.7%、葡萄籽提取物1.9%、花生组织蛋白0.5%、槲皮素磷脂复合物2.55%、松叶菊提取物1.07%、L-茶氨酸0.82%、山竹提取物0.86%、碧萝芷提取物3.8%、菊粉3.4%、芒果果味粉6.2%、大豆油56%、蜂蜡10%、磷脂4%。
实施例5
一种调节气血保健软胶囊,其是由软胶囊体和封装在软胶囊体内的内容物组成,其内容物是由下列重量百分比的组分组成:枸杞提取物4.2%、沙棘籽油2.9%、葡萄籽提取物1%、花生组织蛋白1.2%、槲皮素磷脂复合物3%、松叶菊提取物1.35%、L-茶氨酸2%、山竹提取物1.25%、碧萝芷提取物1%、菊粉7.5%、柠檬果味粉5%、大豆油58.6%、蜂蜡5%、磷脂6%。
实施例6
一种调节气血保健软胶囊,其是由软胶囊体和封装在软胶囊体内的内容物组成,其内容物是由下列重量百分比的组分组成:枸杞提取物3.5%、沙棘籽油4%、葡萄籽提取物2.6%、花生组织蛋白1.7%、槲皮素磷脂复合物1%、松叶菊提取物0.9%、L-茶氨酸0.65%、山竹提取物0.75%、碧萝芷提取物3.4%、菊粉5.2%、凤梨果味粉6.3%、大豆油61%、蜂蜡4%、磷脂5%。
本发明实施例中所给出的调节气血保健软胶囊,由软胶囊体和封装在软胶囊体内的内容物组成,软胶囊体是由明胶、甘油、水按常规比例选用原料,其内容物制成混悬料液,再经过囊体的制作、压丸、干燥、洗丸等工序制成软胶囊,生产出内容物含量为500mg~1000mg/粒的调节气血保健软胶囊。其中,软胶囊的具体制备工艺属于现有技术,不再赘述。
本发明以实施例1所给出的一种调节气血保健软胶囊,做疗效总结如下:
一、一般性资料:应用本发明保健品治疗气血不足症者50例,女44例,男6例。
二、临床表现:
1、一般表现:面色苍白、疲倦无力、头晕耳鸣、昏厥、皮肤干燥、毛发脱落、指甲易裂;
2、呼吸系统:呼吸急促;
3、循环系统:心动过速;
4、消化系统:食欲减退、恶心呕吐、腹胀腹泻、舌淡、口角皲裂;
5、内分泌系统:月经过多或过少甚至闭经。
三、用法和用量:成人每日推荐量为1g。按人体推荐摄入量为每日2次,每次1粒,可长期服用。
三、疗效标准:
(1)显效:体征及症状显著改善;
(2)有效:体征及症状有所改变;
(3)无效:体征无改变,症状如前。
四、治疗效果:口服保健品治疗后,气血不足症状均有一定改善,其中显效33例,有效17例,有效率100%。治疗期间未发生毒副或不良反应作用。
五、典型案例
例1:王某:女,58岁,经常疲劳、没有食欲腹胀恶心、头痛头晕、目眩耳鸣、注意力不集中、失眠、头发干枯没有光泽,经医院诊断为贫血。服用本发明实施例1所给出的调节气血保健软胶囊3个月后,情况明显好转。
例2:于某:女,62岁,经常在稍微运动后有心慌气短现象,并皮肤干燥发黄,指甲干裂,手足麻木,服用本发明实施例1所给出的调节气血保健软胶囊2个月后,情况显著改善。
例3:周某:男,63岁,晚间入睡困难、易惊易醒,夜尿多,打呼噜的声音逐渐变大,指甲出现纵纹,服用本发明实施例1所给出的调节气血保健软胶囊1个月后,晚间惊醒次数明显减少,其他症状也有好转。
例4:张某,女,53岁,经常自汗,畏寒肢冷,失眠多梦,视物昏花,精神恍惚,经医院诊断为贫血,在医院开的治疗贫血的药物,回家吃了几天后开始便秘,并逐渐加重,遂停药。服用本发明实施例1所给出的调节气血保健软胶囊2个月后,情况明显好转。
Claims (2)
1.一种调节气血保健软胶囊,其特征在于:其是由软胶囊体和封装在软胶囊体内的内容物组成,软胶囊体由明胶、甘油、水按常规比例制成,其特征在于:所述的内容物是由下列重量百分比的组分组成:枸杞提取物3.5~7%、沙棘籽油2.5~4%、葡萄籽提取物1~3%、花生组织蛋白0.5~2.5%、槲皮素磷脂复合物1~3%、松叶菊提取物0.5~1.35%、L-茶氨酸0.5~2%、山竹提取物0.5~1.25%、碧萝芷提取物1~4%、菊粉2~7.5%、果味粉5~7%、大豆油55~65%、蜂蜡3~10%、磷脂2~7%,且各组分的重量百分比之和为100%。
2.根据权利要求1所述的一种调节气血保健软胶囊,其特征在于:所述内容物组分的重量百分比分别为:枸杞提取物5.2%、沙棘籽油3.8%、葡萄籽提取物1.2%、花生组织蛋白1.4%、槲皮素磷脂复合物1.6%、松叶菊提取物0.9%、L-茶氨酸0.8%、山竹提取物0.9%、碧萝芷提取物2.2%、菊粉6%、果味粉6%、大豆油60%、蜂蜡6%、磷脂4%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510807176.2A CN105412390A (zh) | 2015-11-22 | 2015-11-22 | 一种调节气血保健软胶囊 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510807176.2A CN105412390A (zh) | 2015-11-22 | 2015-11-22 | 一种调节气血保健软胶囊 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105412390A true CN105412390A (zh) | 2016-03-23 |
Family
ID=55491237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510807176.2A Pending CN105412390A (zh) | 2015-11-22 | 2015-11-22 | 一种调节气血保健软胶囊 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105412390A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709383A (zh) * | 2005-06-22 | 2005-12-21 | 白新鹏 | 美容美体祛斑胶囊剂 |
CN101244110A (zh) * | 2008-03-03 | 2008-08-20 | 郭松 | 一种具有缓解疲劳、增强免疫功能的中药组合物及其制备方法 |
CN101396510A (zh) * | 2008-09-09 | 2009-04-01 | 太仓宇航人生物工程有限公司 | 治疗微量元素缺乏的保健药物 |
CN101780181A (zh) * | 2009-01-16 | 2010-07-21 | 陈祥槐 | 一氧化氮自由基保健品 |
CN103504185A (zh) * | 2012-06-29 | 2014-01-15 | 李光明 | 一种葡萄籽口服胶囊 |
CN103989171A (zh) * | 2014-05-26 | 2014-08-20 | 河南科技大学第一附属医院 | 一种抗衰老美容养颜软胶囊及其制备工艺 |
CN104544130A (zh) * | 2014-12-17 | 2015-04-29 | 山东天地健生物工程有限公司 | 一种改善营养性贫血的软胶囊及其制备方法 |
-
2015
- 2015-11-22 CN CN201510807176.2A patent/CN105412390A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709383A (zh) * | 2005-06-22 | 2005-12-21 | 白新鹏 | 美容美体祛斑胶囊剂 |
CN101244110A (zh) * | 2008-03-03 | 2008-08-20 | 郭松 | 一种具有缓解疲劳、增强免疫功能的中药组合物及其制备方法 |
CN101396510A (zh) * | 2008-09-09 | 2009-04-01 | 太仓宇航人生物工程有限公司 | 治疗微量元素缺乏的保健药物 |
CN101780181A (zh) * | 2009-01-16 | 2010-07-21 | 陈祥槐 | 一氧化氮自由基保健品 |
CN103504185A (zh) * | 2012-06-29 | 2014-01-15 | 李光明 | 一种葡萄籽口服胶囊 |
CN103989171A (zh) * | 2014-05-26 | 2014-08-20 | 河南科技大学第一附属医院 | 一种抗衰老美容养颜软胶囊及其制备工艺 |
CN104544130A (zh) * | 2014-12-17 | 2015-04-29 | 山东天地健生物工程有限公司 | 一种改善营养性贫血的软胶囊及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102715618B (zh) | 一种百合玉竹饮品及其制备方法 | |
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN103266040B (zh) | 美容保健酒 | |
CN105942495A (zh) | 一种养颜阿胶糕及其制备方法 | |
CN102763795A (zh) | 一种益母红糖及其制备方法 | |
CN106418545A (zh) | 一种营养均衡的功能性食品 | |
CN104186750A (zh) | 杜仲花草养生茶 | |
CN101669624B (zh) | 一种具有改善妇女贫血功能的中药八宝茶及其制备方法 | |
CN100540016C (zh) | 减肥美容祛斑混合物及胶囊 | |
CN103142927A (zh) | 一种用于养生与治疗多种疾病的中药配方 | |
CN102258628B (zh) | 一种具有促进排铅作用的中药组合物 | |
CN101912523A (zh) | 一种治疗小儿缺铁性贫血症的中药制剂 | |
CN109730222A (zh) | 酵素复合液及其保健饮料 | |
CN102973687B (zh) | 调节妇女内分泌平衡的口服液 | |
CN102228575A (zh) | 治疗高血压的外用药物及其生产方法 | |
CN1323598A (zh) | 抗疲劳胶囊 | |
CN105250747A (zh) | 一种养生膏 | |
CN113117028A (zh) | 一种排毒养颜美白的中药组合物及制备方法 | |
CN101897940A (zh) | 一种抗疲劳的中药配方及其制备方法 | |
CN105412390A (zh) | 一种调节气血保健软胶囊 | |
CN105214068B (zh) | 一种治疗小儿多发性抽动症的营养组合物及其制备方法 | |
CN104651178A (zh) | 美容保健酒 | |
CN103948734A (zh) | 一种植物防脱发洗发液的制备工艺 | |
CN103371423A (zh) | 一种降火滋阴补气的植物功能饮料 | |
CN103316217A (zh) | 一种治疗心脏病的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160323 |